Ligand Pharmaceuticals LGND Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's other current assets?
- Ligand Pharmaceuticals (LGND) reported other current assets of $5.8M in Q1 2026.
- How has Ligand Pharmaceuticals's other current assets changed year-over-year?
- Ligand Pharmaceuticals's other current assets decreased by 56.4% year-over-year, from $13.29M to $5.8M.
- What is the long-term trend for Ligand Pharmaceuticals's other current assets?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's other current assets has grown at a 8.6% compound annual growth rate (CAGR), from $3.82M to $5.79M.